Synthesis and comparative evaluation of two antiviral agents: β-L- Fd4C and β-D-Fd4C

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 22, 1998, Pages 3245-3250

  Chen, Shu Hui ^a,c   Lin, Stanley ^a   King, Ivan ^a   Spinka, Tracy ^a   Dutschman, Ginger E ^b   Gullen, Elizabeth A ^b   Cheng, Yung Chi ^b   Doyle, Terrence W ^a  

^a Vion Pharmaceuticals Incorporated   (United States)

^b YALE CANCER CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA DEXTRO FLUORODEOXYURIDINE; BETA LEVO FLUORODEOXYURIDINE; LAMIVUDINE; NELFINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; SAQUINAVIR; UNCLASSIFIED DRUG; XYLOSE; ZIDOVUDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DRUG APPROVAL; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MOUSE; NONHUMAN; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

ANIMALIA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032542041     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00599-X     Document Type: Article

References (23)

1. 1. De Clercq, E. Adv. Drug Res. 1988, 17, 1.
2. 2. Wilson, E. K. C & EN. 1996, July 29, 42.
3. 3. Cohen, J. Science 1997, 277, 32.
4. 4. For example, L-FddC displayed impressive activity against both HIV and HBV.
5. 5. (a) Lin, T.-S.; Luo, M.-Z.; Liu, M.-C.; Zhu, Y.-L.; Gullen, E.; Dutschman, G. E.; Cheng, Y.-C. J. Med. Chem. 1996, 39, 1757.
6. (b) Kukhanova, M.; Li, X.; Chen, S. H.; King, I.; Doyle, T. W.; Prusoff, W.; Cheng, Y-C. Molecular Pharmacology 1998, 53, 801.
7. 6. Faraj, A.; Schinazi, R. F.; Joudawlkis, A.; Lesnikowski, Z.; McMillan, A.; Morrow, C. D.; Sommadossi, J-P. Antiviral Res. 1997, A66.
8. 7. Doong, S.-L.; Tasi, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad.Sci. U.S.A. 1991, 88, 8495.
9. 8. Chang, C-N.; Skalski, V.; Zhou, J. H.; Cheng, Y-C. J. Biol. Chem. 1992, 267, 22414.
10. 9. Chen, S. H.; Wang, Q.; Mao, J.; King, I.; Dutschman, G. E.; Gullen, E. A.; Cheng, Y-C.; Doyle, T. W. Bioorg. Med. Chem. Lett. 1998, 8, 1589.
11. 10. (a) Chen, S. H.; Li, X.; Li, J.; Niu, C.; Carmichael, E.; Doyle, T. W. J. Org. Chem. 1997, 62, 3449.
12. (b) Beach, J. W.; Kim, H. O.; Jeong, L. S.; Nampalli, S.; Islam, Q.; Ahn, S. K.; Babu, J. R.; Chu, C. K. J. Org. Chem. 1992, 57, 3887.
13. 11. Gosselin, G.; Bergogne, M.-C.; Imbach, J.-L. In Nucleic Acid Chemistry, Improved and New Synthetic Procedure, Methods and Techniques, Part 4; Townsend, L. B.; Tipson, R. S., Eds.; Wiley: New York, 1991; pp 41-45.
14. 12. Rao, A. V. R.; Mysorekar, S. V.; Gurjar, M. K.; Yadav, J. S. Tetrahedron Lett. 1987, 28, 2183.
15. 13. Fernandez, S.; Hernandez, E. Synth. Commun. 1982, 12, 915.
16. 14. Carnahan, J. C.; Closson, W. D. Tetrahedron Lett. 1972, 13, 3447.
17. 15. (a) Robles, R.; Rodriguez, C.; Izquierdo, I.; Plaza, M. Carbohydrate Res. 1997, 300, 375.
18. (b) Robles, R.; Rodriguez, C.; Izquierdo, I.; Plaza, M., Mota, A. Tetrahedron: Asymmetry 1997, 8, 2959.
19. Also see: Kim, C. U.; Misco, P. F. Tetrahedron Lett. 1992, 33, 5733.
20. 16. Chen, B.-C.; Quinlan, S. L.; Stark, D. R.; Reid, J. G.; Audia, V. H.; George, J. G.; Brundidge, S. P.; Racha, S.; Spector, R. H. Tetrahedron Lett. 1995, 36, 7957.
21. 17. (a) Mellors, J. W.; Dutschman, G. E.; Im, G. J.; Tramontano, E.; Winkler, S. R.; Cheng, Y-C. Mol. Pharm. 1992, 41, 446.
22. (b) Doong, S. I.; Tasi, C. H.; Schinazi, R. F.; Liotta, D. C. Cheng, Y-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495.
23. (c) Ref 20 cited within 5b.